Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice
Life Science Alliance · 2025
DOI: 10.26508/lsa.202503323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Sara Badesso und 15 weiteren Autor:innen. Beteiligte Einrichtung: Gene Therapy for CNS Disorders Program, Center for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Univers…. Hauptthemen laut MEDLINE: Synapses, Cognition, Group IV Phospholipases A2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Given its potential role in supporting cognitive resilience, PLA2G4E has emerged as a compelling therapeutic target in the context of Alzheimer’s disease (AD). However, its physiological functions in the central nervous system remain largely unexplored. In this study, we demonstrate that Pla2g4e expression peaks during early postnatal brain development, coinciding with the rapid formation of synapses. Loss-of-function experiments in primary neuronal cultures revealed that Pla2g4e expression is essential for proper dendritic development and neuronal maturation. In constitutive Pla2g4e knockout mice, we observed significant disruptions in the developmental profiles of cortical synaptic plasticity markers, accompanied by impairments in memory-related behaviors. Notably, the adeno-associated virus–mediated overexpression of PLA2G4E rescued memory deficits, highlighting its functional relevance in cognitive processes. Furthermore, selective deletion of Pla2g4e in excitatory neurons of the adult brain resulted in moderate memory impairments in aged animals, suggesting an ongoing role in synaptic maintenance. Together, these findings establish PLA2G4E as a key regulator of dendritic architecture, synaptic function, and cognitive performance, and highlight its potential as a gene therapy target for neurodegenerative diseases characterized by synaptic dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gene Therapy for CNS Disorders Program, Center for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, Pamplona, Spain.
- Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
- Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, Milan, Italy.
- Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", University of Milan, Milan, Italy.
- DNA and RNA Medicine Division, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
- Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
ORCID-Profile: Marta Perez-Gonzalez, Sara Exposito, Africa Vales, Nico Mitro, Mar Cuadrado-Tejedor, Ana Garcia-Osta
Zitieren
APA
Badesso, S., Perez-Gonzalez, M., Exposito, S., Espelosin, M., Cambria, C., D'Andrea, L., Imperato, G., Moeini, P., Vales, A., Gonzalez-Aseguinolaza, G., Mitro, N., Antonucci, F., Martín, E. D., Marcello, E., Cuadrado-Tejedor, M., & Garcia-Osta, A. (2025). Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice. Life Science Alliance. https://doi.org/10.26508/lsa.202503323
Vancouver
Badesso S, Perez-Gonzalez M, Exposito S, Espelosin M, Cambria C, D'Andrea L, et al. Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice. Life Science Alliance. 2025. doi:10.26508/lsa.202503323
BibTeX
@article{Badesso2025,
author = {Badesso, Sara and Perez-Gonzalez, Marta and Exposito, Sara and Espelosin, Maria and Cambria, Clara and D'Andrea, Laura and Imperato, Gabriele and Moeini, Pedram and Vales, Africa and Gonzalez-Aseguinolaza, Gloria and Mitro, Nico and Antonucci, Flavia and Martín, Eduardo D and Marcello, Elena and Cuadrado-Tejedor, Mar and Garcia-Osta, Ana},
title = {Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202503323}
}
EUVIMED